Key facts
- This page summarizes Samuel Agresta's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2026, 15:25.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
1/48th of the shares subject to the option shall vest on May 1, 2026 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.